Clinical Trial Update: Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating erythropoietin for anemia after autologous hematopoietic stem cell transplantation in lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Lymphoma

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Peking University | Conditions: Anemia, Lymphoma | Phase 4 | Status: UNKNOWN